Search Results 1931-1940 of 19624 for Hemoglobin

1. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

   ... hemoglobin (Hb)A1c, suggesting poorly controlled diabetes - Participants who are on a stable dose of oral diabetes medication >= 2 weeks prior to initiation ...

2. Study to Evaluate the Safety, Tolerability and Antitumor Activity of Anti-B7-H3 Car-T Cell Injection (TX103) in Subjects With Recurrent or Progressive Grade 4 Glioma - Mayo Clinic

   Hematological function: Absolute neutrophil count (ANC) ≥ 1.5×109 /L, hemoglobin (Hb) ≥ 90g/L, platelet count (PLT) ≥ 100×109 /L, absolute lymphocytes ...

3. Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors - Mayo Clinic

   Hemoglobin ≤ 9.0 g/dL. Creatinine ≤ 1.5 x upper limit of normal (ULN) OR calculated (calc.) creatinine clearance ≤ 30 mL/min (calculated by the Cockcroft ...

4. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

   Absolute granulocyte count \<1000; platelets \<80,000; hemoglobin ≤ 7 g/L. 10. Bilirubin ≥ 2 × ULN unless conjugated bilirubin ≤ ULN; alkaline ...

5. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study - Mayo Clinic

   PRE-REGISTRATION: Hemoglobin >= 8 g/dL. PRE-REGISTRATION: Creatinine =< 1.5 x upper limit of normal (ULN) or calculated (calc.) creatinine clearance > 30 mL ...

6. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Hemoglobin < 9 g/dL;; Platelet count < 100,000/µL;; Absolute neutrophil count (ANC) < 1200/µL;; Absolute lymphocyte count (ALC) < 750/µL. 37. Any of the ...

7. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (patients may be transfused to meet this requirement); Creatinine ≤ 1.5 x upper limit of normal (ULN); institutional norms are ...

8. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

   Hemoglobin ≥ 9g/dl;; Total bilirubin within normal institutional limits (except for participants with Gilbert's disease);; AST(SGOT)/ALT(SGPT) ≤ 2.5 ...

9. Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer (HOTT) - Mayo Clinic

   Hemoglobin ≥ 8.5 g/dL. Absolute neutrophil count (ANC) ≥ 1,000/mm3. Platelets ≥ 100,000/mm3. Renal function: Creatinine ≤ 1.3mg/dl Calculated creatinine ...

10. Publications - Matthew K. Tollefson, M.D. - Mayo Clinic

    Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy-Frequently Used, but Is It Necessary? Urol Pract. 2020 Nov; 7(6):554-558. Epub ...